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Abstract
B-1 cells constitute a distinct B cell population with unique phenotypic and functional characteristics. They represent the
main B cell population found in mouse peritoneal and pleural cavities. The communication between B-1 cells and peritoneal
macrophages has been previously studied, and the effect this interaction has on macrophages has been previously
described. Using an in vitro co-culture model, herein we demonstrated that peritoneal macrophages were able to increase
survival rates and to stimulate proliferation of B-1 cells. IL-6 was also found to be important in B-1 cell survival; recombinant
IL-6 increases the percentage of viable B-1 cells in culture. Furthermore, molecules involved in the IL-6 signaling pathway,
such as STAT-3 and Bcl-2, were highly expressed in B-1 cells after co-culture with peritoneal macrophages. IL-6-deficient
peritoneal macrophages were not able to increase B-1 cell survival, confirming the importance of this cytokine. Altogether,
our results indicate a novel mechanism in which peritoneal macrophages are able to regulate the B-1 population via IL-6
secretion.
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Introduction
Homeostasis is essential for the maintenance of life. Once this
equilibrium is disrupted, dynamic interactions are initiated and
different components act together to orchestrate a controlled
response in order to restore conditions to the previous homeostasis.
The immune system is central to the maintenance of homeostasis.
It is essential for minimizing damage that originates from the
environment [1].
During an infection, different molecules are responsible for
recognizing potential pathogens that enter the body. These
receptors initiate a signaling cascade that results in the beginning
of an immune response. To clear the infection completely, there
must be communication between different cell types [2]. These
interactions, which occur both by cell-cell contact and through
secreted soluble factors, are observed in many organs and tissues.
The peritoneal cavity is not an exception. Many researchers have
described the peritoneal milieu as a dynamic environment that can
respond to a variety of stimuli, ranging from BCG (Bacillus
Calmette–Gue´rin) infection to skin transplantation, even if the
stimulus is located outside of the peritoneum [3], [4]. In fact, Palos
et al demonstrated a distinct peritoneal cell response after
inoculating the footpads of mice with an irritant, showing that a
distant stimulus can also affect the peritoneum cavity [5].
B-1 cells are the main B-cell population in the peritoneum of
mice [6]. These cells differ from conventional B lymphocytes (B-2
cells) in many aspects, including localization, surface marker
expression, antibody repertoire, developmental pathways, mor-
phology and function [7,8]. Moreover, Abrahao et al have
demonstrated that the ultrastructure of peritoneal B-1 cells has
no similarity to that of splenic B-2 cells [9]. B-1 cells express typical
B-lineage markers, such as CD19, CD45/B220 and IgM, but
unlike B-2 cells, they lack CD23 [10]. B-1 cells also express the
classical myeloid marker CD11b, and the expression of CD5
characterizes two distinct B-1 subtypes: CD5+ cells are referred to
as B-1a cells, while CD52 cells are described as B-1b cells [7,11].
Additionally, B-1 cells have the ability to secrete IL-10 without
stimulation, and they use this cytokine as an autocrine growth
factor [12].
Communication between B-1 cells and other immune cell
subtypes has been recently elucidated. Russo et al described the
ability of B-1 cells to modulate the cellular composition of BCG-
induced pulmonary granulomatous lesions in mice [3]. Addition-
ally, Nogueira-Martins demonstrated, in a T-cell-mediated allo-
graft rejection model in mice, that B-1 cells permitted the
infiltration of CD8+ T cells rather than T helper lymphocytes
into the allografts [4].
B-1 cells were also described to be important for functional
regulation of macrophages. Using in vivo models, Wong et al.
described the influence that B-1 cells have on macrophage
polarization; B-1 cells drive tumor-associated macrophages to an
alternatively activated phenotype in a B16 melanoma tumor
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model [13]. Moreover, Popi et al. demonstrated that the IL-10
secreted by B-1 cells leads to a decrease in nitric oxide and
hydrogen peroxide production by macrophages, which lowers
their phagocytic capacity in vitro [14]. In agreement with these
data, it was demonstrated that BALB/c mice failed to control a
Paracoccidioides brasiliensis infection when compared to BALB/Xid
mice, which have impaired production of B-1 lymphocytes [15].
This result was attributed to an impairment in macrophage
function because of IL-10 secreted by the B-1 cells [16].
Despite the influence of B-1 cells on many immune cells, little is
known about the possible role of different immune cells on the B-1
population. Based on aforementioned data, we decided to evaluate
the possible influence of peritoneal macrophages on B-1 cells
in vitro. Here, we describe that macrophages can influence B-1 cells
in vitro, mostly by influencing their proliferation and survival.
Methods
Mice
BALB/c, BALB/Xid and C57BL/6 mice, 6–8 weeks of age,
were obtained from the animal facilities of Centro de Desenvolvi-
mento de Modelos Experimentais para Medicina e Biologia
(CEDEME), UNIFESP, Brazil. C57BL/6 IL-6 knockout (KO)
mice, 8 weeks old, were obtained from the University of Sa˜o Paulo
at Ribeira˜o Preto School of Medicine. In the majority of
experiments the BALB/c lineage was utilized, unless indicated
otherwise. This study was approved by the Research Ethical
Committee (0243/07) from Universidade Federal de Sa˜o Paulo,
Brazil, and all efforts were made to minimize suffering.
Peritoneal Cell Culture
B-1 cells were obtained from the peritoneal cavities of mice, as
described elsewhere [17]. Briefly, peritoneal cells were collected
from the abdominal cavity of mice by washing with RPMI-1640
medium (Sigma, St Louis, MO). Cells (56106 cells/ml) were
dispensed onto 6-well plates (Corning Costar, Tokyo, Japan) and
incubated at 37uC in 5% CO2 for 40 minutes. Non-adherent cells
were discarded, and RPMI-1640 containing 10% fetal calf serum
(Cultilab, Campinas, SP, Brazil) (R10) was added to the adherent
fraction, followed by incubation at 37uC in 5% CO2 for 5 days
with no medium renewal. After this procedure, B-1 cells
comprised the main cell type in the non-adherent cell population.
These non-adherent cells (B-1 cells) were collected and used in the
experiments performed. The supernatants of these 5-day cultures
(peritoneal cell-conditioned medium) were collected and used in
some experiments. The adherent fraction of these cultures was also
used as a source of macrophages (Figure S1).
Phenotypic Analysis of Non-adherent and Adherent
Fractions of Peritoneal Cell Cultures by FACS
Cells from non-adherent or adherent fractions of the culture
described above were collected, and their phenotype was
evaluated by fluorescence activated cell sorting (FACS). These
cells were stained with the following antibodies: floating cells were
stained with allophycocyanin (APC) labeled anti-mouse CD19 and
fluorescein-isothiocyanate (FITC) labeled anti-mouse CD23. The
adherent fractions of BALB/c and BALB/Xid mouse cultures were
stained with FITC labeled anti-mouse CD19, phycoerythrin (PE)
rat anti-mouse CD11b and anti-mouse F4/80 biotin-conjugated
antibodies. After washing, these cells were also stained with
streptavidin APC-conjugated antibodies. Anti-CD19, CD23,
CD11b and streptavidin APC-conjugated antibodies were from
BD Biosciences (Pharmingen, San Diego, CA). Anti-F4/80
antibody was from Invitrogen (Life Technologies, Carlsbad, CA).
At each step, cells were maintained for 25 minutes at 4uC
protected from light. Fifty thousand events were acquired on a
BDH FACSCalibur using CELLQUEST software (BD Bioscienc-
es, Mountain View, CA), and data were analyzed using FlowJoH
software (Tree Star).
B-1 Cells and Macrophage Co-cultures
B-1 cells were obtained as described above and cultured in three
different ways: B-1 cells alone (16106 cells - in fresh R10 media);
B-1 cells (16106 cells)+peritoneal adherent cells (16105 cells - in
fresh R10 media) or B-1 cells (16106 cells)+peritoneal-conditioned
medium (B-1 cells+peritoneal cell-conditioned medium). Cells
were obtained from wild type mice (BALB/c), BALB/Xid or IL-6
KO mice, as mentioned in each experiment. Peritoneal-condi-
tioned medium was also obtained from these animals. B-1 cells
were either co-cultured with wild type or IL-6 KO derived
conditioned medium. Alternatively, B-1 cells were cultured with
peritoneal cell-conditioned medium derived from both mouse
strains or co-cultured in a transwell with the macrophages.
Viability Analysis of B-1 Cells by FACS
B-1 cells were washed and stained as described above for
quantification of the CD19+CD232 population. After staining for
cell surface markers, isotonic propidium iodide (PI) (Sigma, ST
Louis, MO) solution (10x) was added to each tube (final
concentration 1x) and incubated for 1 minute. Twenty thousand
events were acquired on a BDH FACSCalibur using CELL-
QUEST software (BD Biosciences, Mountain View, CA).
CFSE-based Proliferation Assay
B-1 cell proliferation was measured using CFSE (Carboxy-
fluorescein diacetate, succinimidyl ester - Molecular Probes,
Eugene, OR, USA) staining. Cells were counted, and 26106 cells
were resuspended in RPMI media and labeled with 5 mM CFSE
at 37uC for 15 minutes. Cells were washed with RPMI 1640
supplemented with 10% FBS and resuspended in R10. Cells were
cultured in 6-well round bottomed plates (16106/well for each
time point) for 24 and 72 hours at 37uC and 5% CO2. Cells were
then harvested, washed with 100 mL PBS with 1% BSA and
stained with peridinin chlorophyll protein (PerCP) anti-mouse
CD23 and APC anti-mouse CD19 (BD Pharmingen, San Diego,
CA) for 25 minutes at 4uC. Cells were then washed with PBS-1%
BSA and resuspended in PBS. Fifty thousand events were acquired
and analyzed on a BD FACSCalibur using CELLQUEST
software (BD Biosciences, Mountain View, CA).
IL-6 Quantification in Culture Supernatant
Supernatants from different co-cultures performed as described
above were collected and stored at 280uC. Later, they were
thawed, and IL-2, IL-4, IL-6, IFN-c, TNF-a, IL-17 and IL-10
were detected using the BD CBA Mouse Th1/Th2/Th17
Cytokine Kit (BD Biosciences, CA, USA). Briefly, 25 mL of each
sample was added to 175 mL of capture beads specific for the
cytokines listed above and PE labeled secondary antibodies.
Samples were incubated for 2 hours at room temperature in the
dark. Two-color flow cytometric analysis was performed using
FACS Canto II (BD Biosciences, Mountain View, CA) and
analyzed using CBA analysis software.
Recombinant IL-6 and Anti-IL-6 Treatments
B-1 cells were obtained as previously described, counted and
cultured alone, with 200, 400 or 800 pg/ml of recombinant IL-6
(BD Biosciences, CA, USA). After 24 and 72 hours, the phenotype
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Figure 1. B-1 cells have their survival and proliferation increased when co-cultivated with peritoneal macrophages. (A) Schematic
representation of gate strategy after 24 hours of culture. Expression of CD19 and PI were evaluated on lymphocyte and dead cell gate (left column).
CD19+PI2 cells (middle column) were analyzed for CD23 expression (right column), and CD23+ population was excluded from all analysis. B-1 cells
cultivated alone (upper panel) or with peritoneal macrophages (lower panel) are shown. (B) Graph represents percentage of viable B-1
(CD19+CD232PI2) cells cultivated alone or with peritoneal macrophages in 24 and 72 hours. (C) Representative dot plots of B-1 cells stained with
CFSE cultured alone (B-1 cells) or with peritoneal macrophages (B-1 cells+macrophage), after 24 hours. (D) Graph represents geometric mean values
of CFSE staining after 24 and 72 hours for B-1 cultivated alone or with peritoneal macrophages. (E) Graph represents percentage of CFSE low B-1 cells
when cultured alone or with peritoneal macrophages.
doi:10.1371/journal.pone.0062805.g001
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and viability of B-1 cells were assessed as previously described.
Alternatively, B-1 cells were treated for 24 hours with anti-IL-6
before or after co-culture with macrophages (BD Biosciences, CA,
USA). The viability of B-1 cells was analyzed by PI staining.
Preparation of Cellular Extracts for Western Blot
B-1 cells were cultured in conditions mentioned above for 24
hours. After this treatment, cells were lysed in hypotonic buffer
(50 mM Tris-HCl pH 7.4, 100 mM NaCl, 50 mM NaF, 0.5%
NP-40, 1 mM NaVO4, 100 mM PMSF, 10 mg/mL leupeptin and
10 mg/mL aprotinin) for 20 minutes on ice. Cell lysates were
centrifuged at 14,000 rpm for 15 minutes at 4uC and the
supernatants were used for Western blotting analysis. Extracts
were stored at 270uC prior to use, and the protein content was
determined by the Bradford method [18].
B-1 cellular extracts were fractionated by SDS–PAGE with 10%
acrylamide under reducing conditions. The proteins were trans-
ferred to nitrocellulose membranes (BioRad, Hercules, CA, USA),
followed by blockage of free sites with TBS containing 5% skim
milk. Anti-pSTAT3 (Cell Signaling Technology, Beverly, MA,
USA), STAT3 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), anti-Bcl2 (Calbiochem, Merck, Darmstadt, Germany) and
anti-b actin (Sigma, St Louis, MO) were used as primary
antibodies, and peroxidase-conjugated goat anti-mouse IgG
(Sigma, St Louis, MO) or anti-rabbit IgG (BioRad, Hercules,
CA, USA) was used as a secondary antibody. The reactions were
developed with a chemiluminescence ECL kit (Amersham
Pharmacia, Uppsala, Sweden).
Statistics
All data represent at least three independent experiments and
are expressed as the mean 6 the standard deviation. Statistical
comparisons were made by the analysis of the variance and by
Tukey’s or Bonferroni’s post-tests. Differences that present p-
values of less than 0.05 were considered statistically significant.
Results
The Presence of Macrophages Increases B-1 Cell Survival
and Proliferation in vitro
Considering that B-1 cells are able to regulate some macro-
phages [13,14], we decided to evaluate if the presence of
peritoneal macrophages would induce changes in the B-1 cell
population in vitro. To evaluate this question, B-1 cells and
macrophages were obtained from peritoneal cell cultures, as
described above (Figure S1).
B-1 cells were cultured alone or in the presence of peritoneal
macrophages for 24 or 72 hours, and the viability and proliferation
rate of B-1 cells were analyzed. Figure 1A shows a schematic
representation of the gate strategy used throughout the figures.
Using forward (FSC) and side scatter (SSC) dot plots, 30,000
events were acquired from gated lymphoid and dead cells
(Figure 1A, left panel). From this population, B-1 cells (CD19+PI2)
made up 67.4% and 91.4% of the viable cells when cultured alone
or in the presence of peritoneal macrophages, respectively
(Figure 1A, middle panel). To exclude any possibility of
conventional B cell contamination, CD23 expression by
CD19+PI2 cells was analyzed (Figure 1A, right panel) and
CD23+ cells were excluded from all analyses. Figure 1B shows
that a significantly higher percentage of B-1 cells
(CD19+CD232PI2) were alive when cultured in the presence of
peritoneal macrophages for 24 or 72 hours than those B-1 cells
cultured alone. Similar results were obtained when B-1 cells were
purified by cell sorting (99% of purity –Figure S3) and cultured
together with peritoneal macrophages for 24 hours (Figure 1F).
As Almeida et al demonstrated, B-1 cells are able to proliferate
in vitro [17], and we wondered if contact with peritoneal
macrophages could modify the B-1 cell proliferation index. Thus,
B-1 cells were stained for CFSE and cultured alone or in the
presence of peritoneal macrophages. Figure 1C shows CFSE
staining of B-1 cells cultured alone or with peritoneal macrophages
for 24 or 72 hours. Analysis of CFSE-labeled cells showed that
peritoneal macrophages significantly increased B-1 cell prolifera-
tion in vitro (Figure 1D and E). On Figure 1D, the geo mean value
of B-1 cells cultured alone after 24 hours were used as reference for
the analysis B-1 cells cultured alone for 72 hours and with
peritoneal macrophage for 24 and 72 hours. Figure 1E shows the
percentage of B-1 cells with low CFSE staining.
Taken together, these data indicate that macrophages influence
the survival and proliferation of B-1 cells in vitro.
Soluble Factors Produced by Peritoneal Macrophages are
Sufficient to Modify B-1 Cell Survival in vitro
Considering that B-1 cell proliferation and survival are
increased in the presence of peritoneal macrophages, we
hypothesized that soluble factors secreted by the peritoneal
macrophages could have an important role in the observed
phenotype. To investigate this hypothesis, B-1 cells were cultured
as indicated: in fresh medium (B-1 cells), in the presence of
peritoneal macrophages (B-1 cells+macrophages) or with perito-
neal cell-conditioned medium (B-1 cells+conditioned medium)
over the course of 24 or 72 hours. As shown in Figure 2A, after
both periods, we observed an increased amount of viable B-1 cells
when these cells were cultured in conditioned medium compared
to B-1 cells cultured alone. When compared to B-1 cells cultured
with peritoneal macrophages, B-1 cells+conditioned medium had
similar viability after 24 hours, and a reduction was noted after 72
hours (Figure 2A). In addition, using different percentages of
conditioned medium resulted in a progressive dilution of soluble
factors and a decrease in the number of viable B-1 cells in culture,
in a dose-dependent manner, either after 24 or 72 hours
(Figure 2B).
To confirm that a soluble factor is essential for the augmented
B-1 cell survival in vitro, B-1 cells were cultured in the top of
transwell chambers placed over peritoneal macrophages. Figure 2C
shows that even without direct contact between macrophages and
B-1 cells, the presence of peritoneal macrophages increased
lymphocyte viability after 24 and 72 hours, as compared to B-1
cells cultured alone. Altogether, these results confirm the presence
of a peritoneal macrophage-derived soluble factor that increased
the survival of B-1 cells.
To eliminate the possibility that B-1 cells present in the
adherent fraction (less than 0.5% as shown in Figure S1) could
maintain B-1 cell survival by producing a soluble factor, the
adherent fraction of BALB/Xid peritoneal cell cultures was used as
the source for peritoneal macrophages. Flow cytometric analysis of
the peritoneal cell culture from BALB/Xid confirmed the
deficiency of B-1 cells (Figure S2). Analysis of the BALB/Xid
adherent fraction showed that it was mainly composed of
peritoneal macrophages, similar to that previously observed in
BALB/c cultures, with 91.3% of cells with the CD11b+F4/80+
phenotype (Figure 3A).
Corroborating the previous data, BALB/Xid peritoneal macro-
phages were also able to significantly increase B-1 cell survival
in vitro after 24 or 72 hours (Figure 3B), when compared to B-1
cells cultured alone. Moreover, when B-1 cells were cultured in the
conditioned medium obtained from the BALB/Xid peritoneal cell
Macrophage-Derived IL-6 Increases B1 Cell Survival
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culture, we observed similar percentages of viable cells compared
to the results with conditioned medium from BALB/c cells; both
were significantly increased compared to B-1 cells cultured alone
(Figure 3B).
Taken together, our results exclude the possibility of B-1 cell
contamination in the adherent fraction and clearly show that
soluble factors produced by peritoneal macrophages can promote
B-1 cell survival in vitro.
IL-6 Increases B-1 Cell Viability
Considering that macrophages produce high amounts of
interleukin-6 (IL-6) and that this cytokine is responsible for
lymphocyte proliferation and survival [19], we evaluated IL-6
levels in our model. Figure 4A shows higher amounts of IL-6
present when B-1 cells were cultured with conditioned medium
derived from BALB/c or BALB/Xid than when B-1 cells were
cultured in fresh medium. Other cytokines were measured (IL-2,
IL-4, IFN-c, TNF-a, e IL-17), however, none were present in
significant concentrations (data not shown). IL-10 was also
detected within the culture, with no difference between groups
(Figure 4B). Furthermore, the role of IL-6 in sustaining the
viability of B-1 cells in culture was also tested by the addition of
recombinant IL-6. Despite a slight increase in the number of
viable cells after the addition of 200 or 400 pg/ml of recombinant
IL-6 over those cells receiving no cytokine, no significant
differences were observed between these groups (Figure 4C).
However, treatment of B-1 cells with 800 pg/ml of recombinant
IL-6 augmented cell viability when compared to B-1 cells cultured
in fresh medium (Figure 4C). Altogether, these data indicate an
important role for IL-6 on B-1 cell survival.
IL-6 Increases pSTAT-3 and Bcl-2 Expression
STAT-3 phosphorylation is one of the main intracellular
consequences of IL-6 binding to its receptor [19]. Therefore, we
evaluated the activation of this signaling pathway in B-1 cells that
were cultured in different conditions. Figure 5A shows a
representative Western blot of B-1 cells cultured alone (Line 1),
in the presence of BALB/c peritoneal macrophages (Line 2), in
peritoneal cell-conditioned medium (Line 3) and with 800 pg/ml
of recombinant IL-6 (Line 4) after 24 hours of culture. Figures 5B
and C show the relative expression of STAT-3 and phosphory-
lated STAT-3 (pSTAT-3), compared to b-actin, in B-1 cells
cultured with the previously described groups. STAT-3 expression
was not significantly different for any of the groups (Figure 5B),
while pSTAT-3 was increased in all groups compared to B-1 cells
cultured alone. Moreover, Figure 5D shows an increase in Bcl-2,
an anti-apoptotic protein that is regulated by the STAT3
transcription factor, in all treated groups when compared to B-1
cells cultured alone. Together, these data strongly support the idea
that IL-6 is responsible for B-1 survival in our model, primarily
through increased Bcl-2 and pSTAT-3 expression. These data
reinforce the hypothesis that IL-6 participates in the survival of B-
1 cells in vitro.
Peritoneal Macrophages Derived from IL-6 KO Mice are
Unable to Maintain B-1 Cell Viability
To confirm the involvement of IL-6 in maintaining B-1 cell
survival in vitro and to determine the source of IL-6 in our in vitro
model, we cultured B-1 cells derived from IL-6 KO or wild type
(WT) mice together with peritoneal macrophages also derived
from these mouse strains. Since the background of IL-6 knockout
mouse is C57BL/6, the wild type animals used in this experiment
were C57BL/6. After 24 hours, the viability of B-1 cells from IL-6
KO or WT mice was significantly reduced after being cultured
with IL-6 KO peritoneal macrophages compared to B-1 cells
cultured with WT macrophages (Figure 6 A). Similarly, B-1 cells
cultured with conditioned medium from WT macrophages had
increased viability when compared to B-1 cells cultured with IL-6
KO-derived conditioned medium (Figure 6B). Moreover, the
overall IL-6 concentration was reduced when B-1 cells were
cultured with IL-6 KO peritoneal macrophages (Figure 6C). These
Figure 2. A soluble factor is essential for B-1 cell survival
in vitro. (A) Graph represents percentage of viable B-1 cells when
cultivated alone, together with peritoneal macrophages or with
conditioned medium, after 24 and 72 hours. (B) Viability was measured
when B-1 cells were cultivated with different concentration of the
conditioned medium. (C) Survival of B-1 cells was evaluated when they
were cultured on transwells placed on peritoneal macrophages.
*p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0062805.g002
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results demonstrate that macrophages are the main source of IL-6
in this system.
Finally, anti-IL-6 was added to cultures and the viability of B-1
cells in vitro was evaluated. When anti-IL-6 was added to the
system, the viability of B-1 cells that were cultured with
macrophages or with conditioned medium was statistically
reduced (Figure 6D). Together, these results corroborate the
importance of IL-6 production by peritoneal macrophages for B-1
cell survival.
Discussion
The role of B-1 cells in the regulation of other immune cells has
been widely reported. It has been demonstrated that B-1 cells
down-regulate macrophage functions in vitro [14], induce macro-
phage polarization to an alternative phenotype [13], modulate T
cell infiltration into allografts [4] and into the pancreas in mice
that spontaneously develop diabetes [20], induce the differentia-
tion of CD4+ T cells to become pro-inflammatory Th17 cells [21]
and also have a tolerogenic function in a model of allergic reaction
[22]. Not only do B-1 cells participate in physiological processes,
but they also have a role in some malignancies. Perez et al have
observed that B-1 lymphocytes can alter the properties of tumor
cells required for invasiveness during metastasis [23]. Further-
more, Mussalem et al [24] demonstrated that B-1 cells are
activated by the administration of Propioniumbacterium acnes,
inducing the expression of molecules involved in capturing and
processing antigens. These interactions with different cell types
indicate that B-1 cells may have an important role in regulating
different classes of immune responses, ranging from innate to
adaptive roles.
Significantly less evidence is available regarding the effects of
different cells on B-1 lymphocytes. We have demonstrated that
melanoma cells are able to modify B-1 cells after their interaction,
leading to both increased cell viability and rate of proliferation
[25]. Moreover, contact with melanoma cells also increases the
Figure 3. BALB/Xid peritoneal macrophages and conditioned medium augment B-1 cell survival. (A) Representative dot plot of BALB/Xid
peritoneal macrophages stained with F4/80, CD11b (left panel) and CD19 (right panel). (B) Graph represents percentage of viable B-1 cells present in
culture after 24 and 72 hours when B-1 cells were cultivated alone, on BALB/c or BALB/Xid peritoneal macrophages or with BALB/c or BALB/Xid
conditioned medium. ***p,0.001.
doi:10.1371/journal.pone.0062805.g003
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survival of B-1 cells after irradiation [25]. In this work, we present
data showing that interaction with peritoneal macrophages also
culminates in modifications of B-1 cells.
Here, we demonstrated that peritoneal macrophages were able
to increase B-1 cell viability and proliferation in vitro. This
information introduces an important new mechanism of B-1 cell
survival. Early reports indicate that B-1 cells are self-renewing
Figure 4. IL-6 increases B-1 cell viability. (A) IL-6 and IL-10 (B) were measured when B-1 cells were cultivated alone or with BALB/c or BALB/Xid
conditioned medium, after 24 and 72 hours. (B) B-1 cells were cultivated alone or with 200, 400 or 800 pg/ml of recombinant IL-6, and their survival
was measured. *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0062805.g004
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cells, maintaining viability through IL-10 production [12].
Production of this cytokine may be an important mechanism
primarily for B-1 cell development because B-1 cells appear earlier
than follicular B cells or macrophages in ontogeny [26]. Thus, the
fact that B-1 cells, during early phases of development, do not
depend on other cells to maintain themselves may be seen as an
evolutionary advantage. Despite that, it seems reasonable that, in
later phases of development, other mechanisms may act together
to maintain B-1 cell viability and regulation. Indeed, immune cells
are finely regulated, and normally, several mechanisms are
responsible for increasing or reducing certain cell types, depending
on what the organism needs to maintain homeostasis.
Moreover, we showed that regulation of B-1 cell viability
occurred mainly through the production of a soluble factor by
peritoneal macrophages. Because B-1 cells are able to migrate
from the peritoneal cavity to an inflammatory focus [17,27,28], it
is important that this regulation might occur at a distance.
Notably, B-1 cells cultured in transwells or with peritoneal-
conditioned medium, despite the increase in viability, had no
increase in their rate of proliferation (data not shown). These
results show that B-1 cell-macrophage contact is also important for
B-1 regulation.
Considering that B-1 cells are capable of self-maintenance
through production of IL-10 [12], it might be postulated that the
peritoneal adherent cells were contaminated by B-1 cells. Despite
Figure 5. IL-6 cytokine increases pSTAT-3 and Bcl-2 expression. (A) Representative western blot of STAT-3, pSTAT-3 and Bcl-2 of B-1 cells
cultivated alone (line 1), with BALB/c peritoneal macrophages (line 2), with BALB/c conditioned medium (line 3) or with 800 pg/ml of recombinant IL-
6 (line 4), after 24 hours. Results are representative of 3 independent experiments. Relative expression of total (B) STAT-3, (C) pSTAT-3 and (D) Bcl-2
compared to b-actin are shown in the graphs. *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0062805.g005
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the demonstration that the main population on adherent fraction
are macrophages, we also excluded this possibility by culturing B-1
cells in the presence of peritoneal macrophages derived from
BALB/Xid, mice, which have impaired production of B-1
lymphocytes [15], or in conditioned medium derived from
peritoneal cells. Similar results were found between these groups.
These data confirm the participation of peritoneal macrophages,
and a macrophage-derived soluble factor, on B-1 cell regulation.
IL-6 is a cytokine produced by several cell types, including
antigen presenting cells, such as macrophages and dendritic cells
[29], and it induces B-cell proliferation [30]. Moreover, B-1 cells
constitutively express high levels of IL-6 receptor [31]. All of these
data strongly indicate that IL-6 could participate in B-1 cell
regulation. Indeed, several experiments confirmed IL-6 participa-
tion in B-1 cell regulation. Not only was the concentration of IL-6
high in conditioned medium, but the addition of recombinant IL-6
was also able to increase B-1 cell viability. Moreover, phosphor-
ylated STAT-3 and Bcl-2 expression was increased when B-1 cells
were cultured with peritoneal macrophages or with conditioned
medium. The IL-6 intracellular cascade includes phosphorylation
of STAT-3 [19], which regulates other anti-apoptotic genes, such
as Bcl-2 [32]. Finally, the addition of anti-IL-6 reduced B-1 cell
viability. Recognizing IL-6 as a B-1 cell regulating factor may have
important consequences. It is known that IL-6 plays a critical role
Figure 6. Peritoneal macrophages derived from IL-6 KO mouse are unable to maintain B-1 cells viability. B-1 cells derived from C57BL/6
wild type or IL-6 KO mouse were cultivated with wild type or IL-6 KO peritoneal macrophages (A), or with conditioned medium derived from IL-6 KO
or WT mouse (B), and viability was measured after 24 hours. (C) IL-6 was measured when B-1 cells derived from wild type or IL-6 KO mouse were
cultivated with wild type or IL-6 KO peritoneal macrophages. (D) Anti IL-6 was added to the culture, and B-1 cells viability was measured. *p,0.05,
**p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0062805.g006
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in the pathogenesis of autoimmune diseases [33], and overpro-
duction of IL-6 has previously been described in rheumatoid
arthritis in humans [34], [35]. Additionally, the involvement of IL-
6 in autoantibody production has been further supported by
studies in human patients and in animal models [33]. Considering
that high levels of B-1 cells have been reported in patients with
Systemic Lupus Erythematosus, Sjogren’s syndrome and rheuma-
toid arthritis [36] and that numerous associations between
expansion of this cell compartment and systemic autoimmunity
have been found in murine models [37], we propose here a link
between these two phenomena. In conditions in which IL-6
production is constitutively high, such as in aging [38] or in
chronic inflammatory situations [39], viable B-1 cells would be
augmented as well. This microenvironment would then be
favorable to the development of autoimmune diseases. It has
already been shown that autoimmunity is more prevalent in these
situations [40]. Whether the B-1 cells of these populations are
somehow altered or present in higher numbers is a question to be
answered. Additionally, in NZB/W F1 mice, a mouse strain that
develops an autoimmune condition accepted as a murine model of
Systemic Lupus Erythematosus [41] and that has a large B-1 cell
population in the peritoneal cavity [7], spontaneous production of
IgG anti-DNA antibodies by splenic B cells was enhanced by IL-6
[42]. IL-6 could have the same effect on B-1 cells because they also
produce anti-DNA antibody [43].
In conclusion, we have shown that peritoneal macrophages are
important for the viability of B-1 cells, mainly by the production of
IL-6. Extrapolating this result to in vivo, we could suggest that an
increase in IL-6 levels could result in the expansion of the B-1 cells
observed in some autoimmune diseases. These findings are
important for the understanding of the biological function of B-1
cells and reveal an as yet unknown mechanism of B-1 cell
regulation.
Supporting Information
Figure S1 B-1 cells and peritoneal macrophages are the
main population of cultures. (A) Analysis of non-adherent
fraction of the peritoneal cells culture demonstrated that B-1 cells,
characterized as CD19+CD232 cells, comprised approximately
80% of non-adherent cells. (B) On adherent fraction, 92.2% of
total cells were CD11b+F4/80+ (left panel), and less than 0.5%
were CD19+ (right panel). These cells were used here as source of
peritoneal macrophages.
(TIFF)
Figure S2 Flow cytometry analysis of peritoneal cells
culture from BALB/Xid. Representative dot plot showing
percentage (3.02%) of B-1 cells (CD19+CD232) of BALB/Xid
peritoneal cell culture.
(TIFF)
Figure S3 Flow cytometry analysis of peritoneal cells
culture after cell sorting. Representative dot plot showing that
99% of the cells present in culture after cell sorting were B-1 cells
(CD19+CD232).
(TIFF)
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